California, the magazine of the Cal Alumni Association, has a moving article by Laura B. Childs about the memorial service for Alexander “Sasha” Shulgin, the renowned psychedelic chemist. “Sasha’s work is by all objective criteria worthy of the very highest academic honors, Nobel Prize kind of...
An article by Kai Kupferschmidt in Science magazine gives a comprehensive survey of current psychedelic research. “High Hopes” focuses on the work of Heffter board member Stephen Ross and includes quotes from board members Roland Griffiths and Franz Vollenweider.“Albert Hofmann, the Swiss chemist who discovered...
According to The Washington Post, new research at Imperial College London shows that subjects injected with the psychedelic drug psilocybin exhibit brain activity that resembles the dreaming state. The researchers found that psilocybin increases activity in parts of the brain associated with emotion, memory, and...
Heffter co-founder David Nichols has an “Editors Pick” article on reset.me, a new web site devoted to journalism on psychedelics and related topics. In “When Will Medicinal ‘Magic Mushrooms’ Be Legalized?” Dr. Nichols gives an overview of Heffter-sponsored research using psilocybin to treat addiction, anxiety,...
An article in the New York Times “Fashion and Style” section covers the current popularity of the psychedelic beverage ayahuasca. The article features quotes from Heffter board member Charles Grob.“‘It”s a fascinating compound with a great deal to be learned from its effects,’ said Dr....
A new study uses fMRI technology to distinguish the effects of MDMA (“Ecstasy”) and the classic psychedelic psilocybin on the networks within the brain. Researchers found that psilocybin produces unique changes in consciousness.The effects of psilocybin and MDMA on between-network resting state functional connectivity in...
The Purdue University independent daily student newspaper, The Exponent, has a featured article about Heffter’s President and co-founder Dr. David Nichols.AP photoby Reed Sellers“A former Purdue professor is making major headway in a revolutionary method of treatment for psychiatric disorders by facilitating controlled psychedelic trips.“Adjunct...
We’re saddened to note the passing of Dr. Alexander “Sasha” Shulgin, an important pioneer of psychedelic chemistry. In addition to a long and remarkably productive career as a chemist, Dr. Shulgin authored a number of influential books including two scientific autobiographies, PIHKAL: A Chemical Love...
Southern California Public Radio station KPCC has an excellent four-part series on the current state of psychedelic research. The series, reported by Health Care Correspondent Stephanie O’Neill, features interviews with Heffter board members George Greer, Charles Grob, and Stephen Ross.“Research into the therapeutic potential of...
A team at the Psychiatric University Hospital of Zurich, including Heffter board member Franz X. Vollenweider, found that psilocybin improves the mood of healthy individuals. According to the Zurich researchers, a moderate dose of psilocybin can lessen the effect of negative stimuli in the amygdala...
